Policy

All articles by Policy

Medicare price negotiations, cancer care and ‘unintended consequences’
Medicare price negotiations, cancer care and ‘unintended consequences’
Lecia Bushak
January 13, 2022
12:40 pm

Some experts argue that the current Build Back Better pricing scheme will hinder cancer research and care.

More COVID, more CDC communications confusion
More COVID, more CDC communications confusion
Lecia Bushak
January 6, 2022
11:16 am

The CDC has tweaked its messaging to focus on harm reduction. It hasn’t made any difference.

MM+M’s top campaign stories of 2021
MM+M’s top campaign stories of 2021
MM+M Staff
December 30, 2021
5:00 am

We rounded up some of our most popular campaign coverage from the past year.

MM+M’s top healthcare policy columns of 2021
MM+M’s top healthcare policy columns of 2021
MM+M Staff
December 29, 2021
5:00 am

We rounded up some of the best received policy columns from the past year.

‘Only mostly dead’? Build Back Better plan up in the air
‘Only mostly dead’? Build Back Better plan up in the air
Lecia Bushak
December 22, 2021
1:00 pm

The Build Back Better act’s drug-pricing reform scheme may be in jeopardy, but it’s not time to write an obituary just yet.

Telehealth key to ensuring access for people with addiction
Telehealth key to ensuring access for people with addiction
Lecia Bushak
December 16, 2021
3:09 pm

A just-released report suggests that states can and should act to maintain pandemic-era telehealth policies for addiction treatment.

“We’ve been waiting for something like this”
“We’ve been waiting for something like this”
Lecia Bushak
December 9, 2021
1:00 pm

Health and policy experts herald the Surgeon General’s acknowledgement of a “mental health crisis” among young people.

The Omicron messaging dilemma
The Omicron messaging dilemma
Lecia Bushak
December 3, 2021
5:10 am

Why public health experts believe communications around Omicron need to toe the line between too much concern and just enough.

Health Policy 2022: Drug pricing reform, midterm elections loom large
Health Policy 2022: Drug pricing reform, midterm elections loom large
Lecia Bushak
December 1, 2021
12:00 pm

The pandemic won’t be in the rearview mirror anytime soon, but healthcare policy wonks expect the focus to shift as the 2022 midterm elections heat up.

The FDA’s upcoming clinical research revamp
The FDA’s upcoming clinical research revamp
Lecia Bushak
November 29, 2021
12:00 pm

Here’s what a restructuring of clinical trials might look like under FDA commissioner pick Dr. Robert Califf.

  • From Our Partners